(Source: Drug and Alcohol Dependence)
See all stories on this topic
Although Blacks and Whites in the United States (US) use and sell drugs at approximately the same rates, Blacks are more than twice as likely to be arrested for drug related reasons than are Whites (Trifiletti, Gielen, Sleet, & Hopkins, 2005; Mitchell, 2015; National Survey, 2013). The mass incarceration of Black men resulting from this bias in drug related arrests has contributed to the social an
See all stories on this topic
Mental health issues like depression and addiction are more common among young transgender women than the general U.S. population, according to a new study. Reuters Health Information (Source: Medscape Medical News Headlines)
See all stories on this topic
March 22, 2016 — In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration today announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, overdose a
See all stories on this topic
The Food and Drug Administration will require boxed warnings on the risks of abuse, misuse, addiction, overdose, and death for all immediate-release opioids. The decision is part of the latest wave of efforts by federal officials to combat the ballooning opioid epidemic. It comes a week after the Centers for Disease Control and Prevention issued guidelines recommending nonopioid analgesia for non
See all stories on this topic
Be First to Comment